DS
LSTA icon

David Shaw’s Lisata Therapeutics LSTA Stock Holding History

David Shaw’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-91
Closed -$8K – 3465
2016
Q2 		$8K Sell
91
-243
-73% -$22.4K ﹤0.01% 3316
2016
Q1 		$37K Sell
334
-461
-58% -$45.3K ﹤0.01% 3347
2015
Q4 		$129K Buy
795
+552
+227% +$101K ﹤0.01% 3646
2015
Q3 		$54K Buy
243
+27
+13% +$6.77K ﹤0.01% 3659
2015
Q2 		$61K Sell
216
-232
-52% -$86.2K ﹤0.01% 3677
2015
Q1 		$171K Buy
448
+261
+140% +$141K ﹤0.01% 3473
2014
Q4 		$106K Buy
187
+49
+36% +$33.4K ﹤0.01% 3900
2014
Q3 		$115K Sell
138
-158
-53% -$138K ﹤0.01% 3967
2014
Q2 		$290K Sell
296
-52
-15% -$50.6K ﹤0.01% 3850
2014
Q1 		$367K Buy
+348
New +$377K ﹤0.01% 3811

Other funds holding LSTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $1.54B AUM 30.1% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

David Shaw's LSTA Position: Q3 2016 in Review

David Shaw sold out of Lisata Therapeutics (LSTA) in Q3 2016, closing a stake of 91 shares — an estimated $8K sold.

David Shaw first reported a position in LSTA in Q1 2014 and held it in 10 quarters. The position peaked at $367K in Q1 2014. 28 funds tracked by Wall St. Rank hold LSTA as of Q3 2016.

  • David Shaw reported no remaining Lisata Therapeutics position as of Q3 2016 after selling out during the quarter.
  • David Shaw sold 91 Lisata Therapeutics shares in Q3 2016, an estimated $8K.
  • David Shaw first reported a position in Lisata Therapeutics in Q1 2014 and held it in 10 quarters.
  • David Shaw's Lisata Therapeutics position peaked at $367K in Q1 2014.
  • 28 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2016.

Based on D.E. Shaw & Co's 13F filing for Q3 2016, filed 14 Nov 2016.